Tiziana Life Sciences Ltd. (NASDAQ: TLSA)
$0.81
N/A ( 0% ) 21.7K
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
Market Data
Open
$0.81
Previous close
$0.81
Volume
21.7K
Market cap
$82.23M
Day range
$0.81 - $0.84
52 week range
$0.41 - $1.05
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 3 | Sep 08, 2023 |
6-k | Quarterly Reports | 3 | Sep 06, 2023 |
6-k | Quarterly Reports | 3 | Sep 01, 2023 |
6-k | Quarterly Reports | 3 | Aug 23, 2023 |
6-k | Quarterly Reports | 3 | Aug 23, 2023 |
6-k | Quarterly Reports | 3 | Aug 17, 2023 |
6-k | Quarterly Reports | 3 | Aug 15, 2023 |
6-k | Quarterly Reports | 3 | Jul 21, 2023 |